Search results
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 6 days agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19...
The two sides of AstraZeneca’s vaccine ‘miracle’
Daily Telegraph· 6 days agoAstraZeneca had been unable to identify the cause of the clots and the Government bought its Covid vaccines for the next year’s rollout from rivals. In...
Two possible bird flu vaccines could be available within weeks, if needed
NBC News via Yahoo News· 5 days agoThe U.S. has two vaccines ready that could begin shipping widely within a few weeks if the H5N1 bird...
High Response Rates With Gene Therapies for BCG-Unresponsive Bladder Cancer
MedPage Today· 3 days agoThree-fourths of patients had complete responses, which proved to be durable in most cases
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 4 days agoWithin minutes of getting the Johnson & Johnson Covid-19 vaccine, Michelle Zimmerman felt pain...
Cardiff Oncology Inc (CRDF) (Q1 2024) Earnings Call Transcript Highlights: Strategic Insights ...
GuruFocus.com via Yahoo Finance· 4 days agoThe company is leveraging Pfizer Ignite's resources to ensure effective trial execution. Q: Could you read some of the scenario planning that you...Q3/Q4 will include about ...
EXPLAINER: Boosters key to fight omicron, lot still to learn
AOL· 5 days ago“Everything is riskier now because omicron is so much more contagious,” said Dr. S. Wesley Long, who...
Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria
Medscape· 4 days agoRecent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK...
Earnings call: Cardiff Oncology reports on CRDF-004 trial progress By Investing.com
Investing.com· 3 days agoCardiff Oncology, a biopharmaceutical company focused on developing new treatments for cancer, has...
Earnings call: Cardiff Oncology reports on CRDF-004 trial progress
Investing.com· 4 days agoCardiff Oncology, a biopharmaceutical company focused on developing new treatments for cancer, has...